Cargando…

Role, Laboratory Assessment and Clinical Relevance of Fibrin, Factor XIII and Endogenous Fibrinolysis in Arterial and Venous Thrombosis

Diseases such as myocardial infarction, ischaemic stroke, peripheral vascular disease and venous thromboembolism are major contributors to morbidity and mortality. Procoagulant, anticoagulant and fibrinolytic pathways are finely regulated in healthy individuals and dysregulated procoagulant, anticoa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Memtsas, Vassilios P., Arachchillage, Deepa R. J., Gorog, Diana A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867291/ https://www.ncbi.nlm.nih.gov/pubmed/33540604 http://dx.doi.org/10.3390/ijms22031472

Ejemplares similares

Measuring Thrombus Stability at High Shear, Together With Thrombus Formation and Endogenous Fibrinolysis: First Experience Using the Global Thrombosis Test 3 (GTT-3)
por: Kanji, Rahim, et al.
Publicado: (2023)

Fibrinolysis in Platelet Thrombi
por: Kanji, Rahim, et al.
Publicado: (2021)

Apixaban enhances endogenous fibrinolysis in patients with atrial fibrillation
por: Spinthakis, Nikolaos, et al.
Publicado: (2019)

Importance of Endogenous Fibrinolysis in Platelet Thrombus Formation
por: Gue, Ying X., et al.
Publicado: (2017)

Inhibition of Fibrinolysis by Coagulation Factor XIII
por: Rijken, Dingeman C., et al.
Publicado: (2017)

Factor XIII and Fibrin Clot Properties in Acute Venous Thromboembolism
por: Ząbczyk, Michał, et al.
Publicado: (2021)

Coagulation Factor XIII in Cerebral Venous Thrombosis
por: Li, Bojun, et al.
Publicado: (2019)

Point-of-care platelet function tests: relevance to arterial thrombosis and opportunities for improvement
por: Gorog, Diana A., et al.
Publicado: (2020)

Determinants of Endogenous Fibrinolysis in Whole Blood Under High Shear in Patients With Myocardial Infarction
por: Kanji, Rahim, et al.
Publicado: (2022)

Precision Treatment in ACS–Role of Assessing Fibrinolysis
por: Gue, Ying X., et al.
Publicado: (2021)

Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19
por: Wygrecka, Malgorzata, et al.
Publicado: (2022)

Physical Determinants of Fibrinolysis in Single Fibrin Fibers
por: Bucay, Igal, et al.
Publicado: (2015)

Impaired endogenous fibrinolysis at high shear using a point-of-care test in STEMI is associated with alterations in clot architecture
por: Spinthakis, Nikolaos, et al.
Publicado: (2019)

THE CONVERSION OF FIBRINOGEN TO FIBRIN : XIII. DISSOLUTION OF FIBRIN AND INHIBITION OF CLOTTING BY VARIOUS NEUTRAL SALTS
por: Shulman, Sidney, et al.
Publicado: (1953)

Thrombin-Activatable Fibrinolysis Inhibitor Polymorphisms and Cerebral Venous Thrombosis in Mexican Mestizo Patients
por: Arauz, Antonio, et al.
Publicado: (2018)

Evaluation of Coagulation, Fibrinolysis and Endothelial Biomarkers in Cirrhotic Patients With or Without Portal Venous Thrombosis
por: Ren, Wenhua, et al.
Publicado: (2020)

Clot Structure and Fibrinolysis in Thrombosis and Hemostasis
por: Bagoly, Zsuzsa, et al.
Publicado: (2017)

Altered fibrin network structure and fibrinolysis in intensive care unit patients with COVID‐19, not entirely explaining the increased risk of thrombosis
por: de Vries, Judith J., et al.
Publicado: (2022)

Fibrinolysis and Inflammation in Venous Thrombus Resolution
por: Mukhopadhyay, Subhradip, et al.
Publicado: (2019)

Fibrinolysis Shutdown and Thrombosis in Severe COVID-19
por: Seheult, Jansen N., et al.
Publicado: (2020)

Catheter ablation for AF improves global thrombotic profile and enhances fibrinolysis
por: Niespialowska-Steuden, Maria, et al.
Publicado: (2017)

Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysis
por: Mutch, N J, et al.
Publicado: (2010)

Accelerated fibrin clot degradation is associated with arterial thromboembolism in patients following venous thrombosis: a cohort study
por: Mrozinska, Sandra, et al.
Publicado: (2021)

Association of Heparin-Like Effect, Factor VII/XIII Deficiency and Fibrinolysis with Rebleeding Risk in Cirrhosis with Acute Variceal Bleeding
por: Premkumar, Madhumita, et al.
Publicado: (2022)

Time course of thrombosis and fibrinolysis during total hip surgery
por: Reikerås, O., et al.
Publicado: (2006)

Blood Accessibility to Fibrin in Venous Thrombosis is Thrombus Age-Dependent and Predicts Fibrinolytic Efficacy: An In Vivo Fibrin Molecular Imaging Study
por: Stein-Merlob, Ashley F., et al.
Publicado: (2015)

Acute Vertebral Artery Origin Occlusion Leading to Basilar Artery Thrombosis Successfully Treated by Angioplasty with Stenting and Intracranial Fibrinolysis
por: Matsubara, Noriaki, et al.
Publicado: (2013)

Streptococcal inhibitor of complement (SIC) modulates fibrinolysis and enhances bacterial survival within fibrin clots
por: Frick, Inga-Maria, et al.
Publicado: (2018)

Fibrinolysis-resistant carbonylated fibrin detected in thrombi attached to the vascular wall of abdominal aortic aneurysms
por: Suzuki, Yuko, et al.
Publicado: (2020)

The Deleterious Effects of Impaired Fibrinolysis on Skeletal Development Are Dependent on Fibrin(ogen), but Independent of Interlukin-6
por: Cole, Heather A., et al.
Publicado: (2021)

The degradation of gelatin/alginate/fibrin hydrogels is cell type dependent and can be modulated by targeting fibrinolysis
por: Boucard, Elea, et al.
Publicado: (2022)

Rationale and design of “Can Very Low Dose Rivaroxaban (VLDR) in addition to dual antiplatelet therapy improve thrombotic status in acute coronary syndrome (VaLiDate-R)” study: A randomised trial modulating endogenous fibrinolysis in patients with acute coronary syndrome
por: Gue, Ying X., et al.
Publicado: (2019)

Echocardiographic and radiological evaluation of an unusual aortic root mass in an asymptomatic patient: a case report
por: Memtsas, Vassilios, et al.
Publicado: (2019)

Reduced model to predict thrombin and fibrin during thrombosis on collagen/tissue factor under venous flow: Roles of γ’-fibrin and factor XIa
por: Chen, Jason, et al.
Publicado: (2019)

The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies
por: Longstaff, Colin, et al.
Publicado: (2011)

Reduced Plasma Magnesium Levels in Type-1 Diabetes Associate with Prothrombotic Changes in Fibrin Clotting and Fibrinolysis
por: Sobczak, Amélie I. S., et al.
Publicado: (2020)

Arterial and Venous Thrombosis in Cancer Patients
por: Blann, Andrew D., et al.
Publicado: (2011)

Neonatal renal venous and arterial thrombosis
por: Motta, Mario
Publicado: (2015)

Screening for venous thromboembolism in patients with COVID-19
por: Vandenbriele, Christophe, et al.
Publicado: (2021)

Factor XIII in the Acute Care Setting and Its Relevance in Obstetric Bleeding
por: Duque, Patricia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5lrle64n17kobj2fl2eqo2u5j1